What's new

EMA recommendation to update the antigenic composition of authorised COVID-19 vaccines for 2025-2026

EMA recommendation to update the antigenic composition of authorised COVID-19 vaccines for 2025-2026

May 16, 2025 - 12:42
 0
EMA recommendation to update the antigenic composition of authorised COVID-19 vaccines for 2025-2026
Read More

Tags:

Previous Article

STAT+: Lars Fruergaard Jørgensen, CEO of Novo Nordisk, to step down as company s...

Next Article

Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, D...

Related Posts

Human medicines European public assessment report (EPAR): Briumvi, ublituximab, Date of authorisation: 31/05/2023, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

May 6, 2025  0

Supporting innovation

Supporting innovation

May 8, 2025  0

EMEA-002689-PIP02-23

EMEA-002689-PIP02-23

May 13, 2025  0